北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (1): 6-015. doi: 10.3969/j.issn.1671-167X.2017.01.002

• 论著 • 上一篇    下一篇

骨形态发生蛋白-2-磷酸钙共沉淀支架与人脂肪间充质干细胞构建新型组织工程化骨

姜蔚然1*,张晓1*,刘云松1,吴刚2,葛严军1△,周永胜1   

  1. [1.北京大学口腔医学院·口腔医院,修复科口腔数字化医疗技术和材料国家工程实验室口腔数字医学北京市重点实验室, 北京100081;2. Department of Oral Implantology and Prosthetic Dentistry, Academic Centre for Dentistry Amsterdam (ACTA), Research Institute MOVE, VU University and University of Amsterdam, Amsterdam, the Nether-lands 1081 LA]
  • 出版日期:2017-02-18 发布日期:2017-02-18
  • 通讯作者: 葛严军
  • 基金资助:

    国家自然科学基金(81400484)和北京大学口腔医院青年科研基金项目(YS020213)资助

A novel tissue-engineered bone constructed by using human adipose-derived #br# stem cells and biomimetic calcium phosphate scaffold coprecipitated with #br# bone morphogenetic protein-2

  • Online:2017-02-18 Published:2017-02-18
  • Supported by:

    Supported by the National Natural Science Foundation of China (81400484) and Youth Foundation of Peking University School and Hospital of Stomatology (YS020213)

摘要:

目的:构建可缓释骨形态发生蛋白-2(bone morphogenetic protein-2, BMP-2)的仿生磷酸钙(biomimetic calcium phosphate,BioCaP)共沉淀三维支架(BMP-2-coprecipitated biomimetic calcium phosphate,BMP-2-BioCaP),检测其理化特性,探究其对人脂肪间充质干细胞(human adiposederived stem cells, hASCs)体内外成骨分化的影响,最终构建以hASCs和BMP-2-BioCaP为基础的新型组织工程化骨。方法:构建BMP-2-BioCaP三维缓释支架,扫描电子显微镜观察表面形貌,体外检测其缓释能力。将BMP-2-BioCaP颗粒分别浸泡于增殖培养基(proliferation medium, PM)与成骨诱导培养基(osteogenic medium,OM)中,每2天提取上清液用于hASCs的体外培养。CCK-8实验检测各组hASCs的体外增殖能力,诱导7 d及14 d后进行碱性磷酸酶(alkaline phosphatase, ALP)染色及活性定量检测,14 d及21 d进行茜素红染色及矿化沉积定量分析,4 d及14 d检测成骨相关基因的表达情况。体内实验使用6只裸鼠,于其背部正中做皮肤切口,向两侧共分离出4个皮下植入腔,分别植入:(1)单纯BioCaP支架,(2)BioCaP支架+hASCs,(3)BMP-2-BioCaP缓释支架,(4)BMP-2-BioCaP缓释支架+hASCs(实验组)。植入4周后取材,标本制成组织学切片进行HE染色观察。结果:BioCaP表面由不规则晶体组成三维立体多孔结构,孔直径约为5~10 μm,加入BMP-2后,不影响BioCaP原有的立体结构。缓释曲线结果显示,蛋白质在前2天释放速度较快,随后释放速度放缓并于5 d后趋于平稳,之后每天释放量较稳定,至第21天仍有少量释放,累积释放量达20%。CCK-8结果显示,BMP-2-BioCaP缓释支架不会影响hASCs的早期增殖。诱导7 d与14 d后,OM+BMP-2-BioCaP组ALP染色及活性定量检测均显著高于其他组(P<0.01)。诱导21 d后,OM+BMP-2-BioCaP组矿化结节染色及钙沉积定量检测均高于其他组(P<0.01)。诱导4 d时OM+BMP-2-BioCaP组的Runt相关转录因子2基因(Runt-related transcription factor 2,RUNX2)与ALP基因表达水平较对照组显著升高(P<0.01),诱导14 d时RUNX2、ALP、骨桥蛋白(osteopontin,OPN)和骨钙素(osteocalcin, OC)基因表达量均显著高于其他组(P<0.01)。HE染色分析可见,实验组和BMP-2-BioCaP缓释支架组中,细胞外基质呈强嗜酸性,出现类似骨陷窝的结构,并可见包含其中的类骨细胞。与BMP-2-BioCaP缓释支架组相比,实验组的细胞外基质嗜酸性更强,类骨组织的面积更大,结构更加典型,其他组未见矿化基质和类骨组织形成。结论:BMP-2-BioCaP支架能够实现BMP-2的良好缓释,并能显著促进hASCs的体内外成骨分化,以hASCs和BMP-2-BioCaP为基础构建的新型组织工程化骨具有潜在的应用前景。

关键词: 骨形态发生蛋白质类, 磷酸钙类, 沉淀, 人脂肪间充质干细胞, 组织工程

Abstract:

Objective: To construct a novel biomimetic calcium phosphate (BioCaP) scaffold loaded with bone morphogenetic protein-2 (BMP-2), and to investigate its role in the osteogenesis of human adipose-derived stem cells (hASCs) in vitro and in vivo. Methods: The BioCaP scaffold coprecipitated with BMP-2 (BMP-2-BioCaP) was constructed in this study. Field emission scanning electron microscopy (SEM) was used to analyze the morphology of the surfaces. The release kinetics was measured to evaluate the slow-release characteristics in vitro. BMP-2-BioCaP was immersed in proliferation medium (PM) or osteogenic medium (OM), respectively. The supernatants were collected and used to culture hASCs in vitro. Cell numbers were determined using the cell-counting kit-8 (CCK-8) to assess the cell proliferation. After 7 and 14 days, alkaline phosphatase (ALP) staining and quantification were performed to test the activity of ALP. After 14 and 21 days, the calcification deposition was determined by alizarin red S (ARS) staining and quantification. The expressions of the osteoblast-related genes were tested on day 4 and day 14. In the in vivo study, 6 nude mice were used and implanted subcutaneously into the back of the nude mice for 4 groups: (1) BioCaP scaffold only, (2) BioCaP scaffold+hASCs, (3) BMP-2-BioCaP scaffold, (4) BMP-2-BioCaP scaffold+hASCs (test group). After 4 weeks of implantation, hematoxylin-eosin (HE) staining was performed to evaluate the in vivo osteogenesis of hASCs. Results: SEM observations showed that BioCaP and BMP-2-BioCaP scaffold were entirely composed of straight, plate-like and sharp-edged crystal units, and the length of the crystal units varied between 5 and 10 μm. Release kinetics analysis demonstrated that BMP-2 incorporated with BioCaP could be released at certain concentration and last for more than 21 days, and the accumulative protein release could reach 20%. CCK-8 assays showed that cell proliferation was not significantly affected by BMP-2-BioCaP. ALP activity was higher by the induction of OM+BMP-2-BioCaP than of the other groups (P<0.01). More mineralization deposition and more expressions of osteoblast-related genes such as Runt-related transcription factor 2 (RUNX2), ALP, osteopontin (OPN) and osteocalcin (OC) were determined in the OM+BMP-2-BioCaP group at different time points (P<0.01). HE staining showed that, in the test group and BMP-2-BioCaP scaffold group, the extracellular matrix (ECM) with eosinophilic staining were observed around hASCs, and newly-formed bone-like tissues could be found in ECM around the scaffold materials. Moreover, compared with the BMP-2-BioCaP scaffold group, more bone-like tissues could be observed in ECM with typical structure of bone tissue in the test groups. No obvious positive results were found in the other groups. Conclusion: BMP-2-BioCaP scaffold could achieve slow-release of BMP-2 and promote the osteogenic differentiation of hASCs in vitro and in vivo. The novel tissue-engineered bone composed of hASCs and BMP-2-BioCaPis promising for the repair of bone defect.

Key words: Bone morphogenetic proteins, Calcium phosphates, Precipitation, Human adipose-derived stem cells, Tissue engineering

中图分类号: 

  • R329.2
[1] 敖英芳,曹宸喜. 解析与重塑软骨组织修复再生微环境[J]. 北京大学学报(医学版), 2021, 53(5): 819-822.
[2] 黄丽东,宫玮玉,董艳梅. 生物活性玻璃对人脐静脉血管内皮细胞增殖及成血管的作用[J]. 北京大学学报(医学版), 2021, 53(2): 371-377.
[3] 王梅, 李博文, 王思雯, 刘玉华. 猪小肠黏膜下层海绵的制备及促成骨作用[J]. 北京大学学报(医学版), 2020, 52(5): 952-958.
[4] 白向松,吕珑薇,周永胜. Tribbles同源蛋白3抑制人脂肪间充质干细胞成脂向分化[J]. 北京大学学报(医学版), 2020, 52(1): 1-9.
[5] 梁晨,张维宇,胡浩,王起,方志伟,许克新. 膀胱扩大术两种不同术式的疗效及并发症比较[J]. 北京大学学报(医学版), 2019, 51(2): 293-297.
[6] 李榕,陈科龙,王勇,刘云松,周永胜,孙玉春. 骨组织工程支架3D打印系统的建立与支架宏微结构精度的可控性评价[J]. 北京大学学报(医学版), 2019, 51(1): 115-119.
[7] 王子成,程立,吕同德,苏黎,林健,周利群. 炎症因子预处理的脂肪干细胞可明显抑制外周血单个核细胞增殖[J]. 北京大学学报(医学版), 2018, 50(4): 590-594.
[8] 宫玮玉,刘绍清,董艳梅,高学军,陈晓峰. 纳米生物活性玻璃促进兔颅骨临界骨缺损修复[J]. 北京大学学报(医学版), 2018, 50(1): 42-48.
[9] 隋华欣, 吕培军, 王宇光, 王勇, 孙玉春. 低能量激光照射对人脂肪基质细胞增殖分化的影响[J]. 北京大学学报(医学版), 2017, 49(2): 337-343.
[10] 张晓,刘云松,吕珑薇,陈彤,吴刚,周永胜. 骨形态发生蛋白2/7异二聚体对人脂肪间充质干细胞成骨分化的促进作用[J]. 北京大学学报(医学版), 2016, 48(1): 37-44.
[11] 郑扬, 李危石, 刘忠军. 骨组织3D打印:骨再生的未来[J]. 北京大学学报(医学版), 2015, 47(2): 203-206.
[12] 徐璐, 王超, 沈文文, 祁荣. 辛伐他汀纳米脂质体对骨髓间充质干细胞成骨分化的影响[J]. 北京大学学报(医学版), 2014, 46(6): 883-888.
[13] 薛世华, 吕培军, 王勇, 赵雨, 张婷. 人牙髓细胞共混物三维生物打印技术[J]. 北京大学学报(医学版), 2013, 45(1): 105-108.
[14] 李芳芳*, 乔朋艳, 董利民, 刘玉华, 徐韬, 谢秋菲. CPC固化中海藻酸钙凝胶微球对细胞的保护及相关影响因素[J]. 北京大学学报(医学版), 2013, 45(1): 33-39.
[15] 周永胜, 吕珑薇, 刘云松. 人脂肪基质细胞与骨再生——从实验室到临床[J]. 北京大学学报(医学版), 2013, 45(1): 1-4.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 郭岩, 谢铮. 用一代人时间弥合差距——健康社会决定因素理论及其国际经验[J]. 北京大学学报(医学版), 2009, 41(2): 125 -128 .
[3] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报(医学版), 2009, 41(2): 135 -140 .
[4] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报(医学版), 2009, 41(2): 158 -161 .
[5] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报(医学版), 2009, 41(2): 217 -220 .
[6] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报(医学版), 2009, 41(1): 52 -55 .
[7] 董稳, 刘瑞昌, 刘克英, 关明, 杨旭东. 氯诺昔康和舒芬太尼用于颌面外科术后自控静脉镇痛的比较[J]. 北京大学学报(医学版), 2009, 41(1): 109 -111 .
[8] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报(医学版), 2009, 41(3): 297 -301 .
[9] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报(医学版), 2009, 41(5): 599 -601 .
[10] 李伟军, 邢晓芳, 曲立科, 孟麟, 寿成超. PRL-3基因C104S位点突变体和CAAX缺失体的构建及表达[J]. 北京大学学报(医学版), 2009, 41(5): 516 -520 .